Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
600
Trial Sponsor
Clinical Trial Start Date
June 1, 2024
0Primary Completion Date
June 1, 2026
0Study Completion Date
June 1, 2029
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Interventional Trial Phase
Not Applicable0
Official Name
Efficacy of Upadacitinib After Autologous Non-cultured Epidermal Cell Suspension Transplantation in Vitiligo Participants -- a Pilot, Random, Observer Blinded, Comparative Study0
Last Updated
June 12, 2024
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Single0
Masked Party
Outcomes Assessor0
Other attributes
Intervention Treatment
Upadacitinib 15 MG0
Study summary
The goal of this clinical trial is to investigate the efficacy of upadacitinib after NECS in participants with vitiligo. The main question it aims to answer is: whether the short time use of upadacitinib after NECS will improve NECS efficacy. Participants in the experimental group will receive upadacitinib after NECS, while Participants in the control group will receive NECS only.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
